November 21, 2026

7 more years needed to develop Dengue vaccine

It will take around seven more years to get a vaccine, which is safe and effective against all four strains of the dengue virus, an expert said.

bdnews24.com News Service

bdnews24.com

Published : 08 May 2006, 06:00 PM

Updated : 17 Aug 2022, 06:10 PM

Farid Ahmed BDNEWS Writer Advisory: with photo Honolulu (Hawaii), May 9 (BDNEWS) - It will take around seven more years to get a vaccine, which is safe and effective against all four strains of the dengue virus, an expert said. "May be the trial (of vaccines now being tested) would be completed by five years and then get approval by two years from various organisations," Professor Duane J. Gubler, Director of Hawaii-based Asia Pacific Institute for Tropical Medicine and Infectious Disease University of Hawaii, told BDNEWS. He said there are now six vaccines being tried, but it would take time to draw a conclusion on their effectiveness. Dengue fever is transmitted by the Aedes aegypti mosquito, which bites during daylight. For the last several years, Bangladesh has been witnessing the menace that caused death of hundreds of people across the country. Talking to BDNEWS, Prof Gubler, who has been working on dengue and dengue hemorrhagic fever for the past 35 years, said they had made a commitment 30 years ago during a meeting in Singapore to develop dengue vaccine. "But we still have a few more years before we can really use it as a shield against the mosquito-borne disease." Asked about the stage of the research work for the vaccine, he said they are now in clinical and pre-clinical stage. One of the vaccines in the US is now at phase II, he added. Gubler said it is important to develop the vaccine soon as the dengue endemic would get worse this century due to the rapid growth in population, globalisation and urbanisation. Among institutions in the advanced stage of developing the vaccine are Thailand's Mahidol University and Walter Reed Army Institute of Research (WRAIR). The Bill Gates Foundation had also been given a grant of US$55 million for dengue research. Asked about the challenges the researchers facing, the professor said the animals are not good models to test the vaccines. On the possible cost of the vaccines being tried, he said: "It is difficult to predict now. But I hope it would be US $ 5 per doze. Each person will have to take two dozes. Research is now going on if it can be made single dozes." The vaccine being developed at Mahidol, which received a US$10 million grant from WHO 10 years ago, is still in the process of human trials. Before 1950, dengue epidemics occurred in the region at an interval of 10 to 20 years. But now these are occurring in every two to three years. According to World Health Organisation (WHO), dengue is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. It has spread to previously unaffected countries like Bangladesh, Bhutan and Queensland in Australia. In the western pacific region, 1.8 million cases of dengue were reported between 1991 and 2004, with a fatality rate of 0.5 percent. According to WHO, countries reporting maximum cases of dengue include Vietnam, Malaysia, the Philippines, Cambodia, Laos, Singapore, French Polynesia, New Caledonia and China. Dr Gubler worked on developing new methods for isolation and identification of dengue virus cases. In the Caribbean, Dr. Gubler directed the development of the CDC Dengue Laboratory, which now serves as a world reference laboratory for diagnosis, surveillance, prevention and control of dengue epidemic. BDNEWS/1613 hrs
Related Stories